CLINICAL_TRIALS ClinicalTrials.gov record update

Introduction of Tandem Mass Spectrometry (MS/MS) Technology in the Program of Selective Screening of Hereditary Metabolic Diseases in Kazakhstan

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05910151
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:06.728323+00:00
Published At: 2023-06-18T00:00:00+00:00
Record Updated At: 2023-06-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions: ["Propionic/Methylmalonic Acidemias", "Maple Syrup Urine Disease", "Citrullinemia", "Argininosuccinic Aciduria", "Ornithine Transcarbamylase Deficiency", "Carbamoyl Phosphate Synthetase I Deficiency", "N-acetylglutamate Synthase Deficiency", "Nonketotic Hyperglycinemia", "Tyrosinemia", "Homocystinuria", "Arginase Deficiency", "Isovaleric Acidemia", "Short/Branched Chain Acyl-CoA Dehydrogenase Deficiency", "Isobutyryl-CoA Dehydrogenase Deficiency", "Glutaric Acidemia Type I", "3-methylcrotonyl-CoA Carboxylase Deficiency", "Biotinidase Deficiency", "Malonyl-CoA Decarboxylase Deficiency", "Beta-ketothiolase Deficiency", "3-hydroxy-3-methylglutaryl-CoA Lyase Deficiency", "3-methylglutaconyl-CoA Hydratase Deficiency", "Medium-chain Acyl-CoA Dehydrogenase Deficiency", "Very Long-chain Acyl-CoA Dehydrogenase Deficiency", "Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency", "Glutaric Acidemia Type II", "Primary Carnitine Deficiency", "Carnitine Palmitoyltransferase I Deficiency", "Carnitine Palmitoyltransferase II Deficiency", "Carnitine-acylcarnitine Translocase Deficiency"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-06-18"
protocolSection.identificationModule.nctId: "NCT05910151"
protocolSection.identificationModule.officialTitle: "Introduction of Tandem Mass Spectrometry (MS/MS) Technology in the Program of Selective Screening of Hereditary Metabolic Diseases in Kazakhstan"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Study condition terms

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.